MedPath

Comparación del efecto de LY2189265 frente a insulina glargina, administrados en combinación con insulina lispro, para el tratamiento hasta alcanzar el objetivo, en pacientes con diabetes mellitus tipo 2 - GBDD

Phase 1
Conditions
Diabetes Mellitus Tipo 2
MedDRA version: 12.1Level: LLTClassification code 10012601Term: Diabetes mellitus
Registration Number
EUCTR2010-019223-55-ES
Lead Sponsor
illy S.A.
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Recruiting
Sex
All
Target Recruitment
925
Inclusion Criteria

Véase el protocolo para más detalles.
Are the trial subjects under 18? no
Number of subjects for this age range:
F.1.2 Adults (18-64 years) yes
F.1.2.1 Number of subjects for this age range
F.1.3 Elderly (>=65 years) yes
F.1.3.1 Number of subjects for this age range

Exclusion Criteria

Véase el protocolo para más detalles.

Study & Design

Study Type
Interventional clinical trial of medicinal product
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath